Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study
JAAD International
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S2666328726001744?dgcid=rss_sd_all
Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study. JAAD International. https://www.sciencedirect.com/science/article/pii/S2666328726001744?dgcid=rss_sd_all
“Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study.” JAAD International.
@article{article50315,
title = {Cutaneous viral infection risk with oral Janus kinase inhibitors in atopic dermatitis: An exploratory single-center retrospective cohort study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S2666328726001744?dgcid=rss_sd_all}
}